远程管理恶化的心力衰竭,以避免在现实世界中住院治疗
Sylvain Ploux1,2, Marc Strik1,2, F Daniel Ramirez3,4
1Cardio-Thoracic Unit, Bordeaux University Hospital (CHU), Pessac, France.
ESC heart failure
|October 5, 2023
概括
恶化的心力衰竭 (WHF) 的远程管理是可行的和安全的. 这种多参数方法可以减少住院,使患者和医疗保健系统受益.
科学领域:
- 心脏病学 心脏病学
- 远程医疗远程医疗
- 医疗信息学 医疗信息学
背景情况:
- 作为门诊患者,管理恶化的心力衰竭 (WHF) 是患者和医疗保健系统的优先事项.
- 远程管理可以早期检测WHF,促进及时干预,防止住院.
研究的目的:
- 评估远程管理WHF事件的可行性和安全性.
- 评估心力衰竭患者多参数远程监测平台的有效性.
主要方法:
- 一项前性研究包括161名慢性心力衰竭患者 (NYHA ≥II) 进行远程管理.
- 多参数评估包括体重,血压,心率,症状,生物标志物 (BNP) 和设备数据.
- 随访数据收集的平均时间为291天.
主要成果:
- 32.3%的患者经历了105次WHF事件; 63%的患者被远程管理.
- 300天无WHF事件和住院率分别为66%和85%.
- 与住院治疗相比,远程管理导致较少的阳性并发症 (3%对26%).
结论:
- 远程,多参数管理WHF事件是可行的和安全的.
- 这一策略可以减少与心力衰竭相关的住院治疗.
- 远程医疗为患者,护理提供者和医疗保健系统提供了好处.
相关概念视频
Heart Failure V: Medical Management
10
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10
Heart Failure VII: Nursing Interventions
86
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
86
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Heart Failure III: Clinical Manifestations
22
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
22
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
445
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
445


